Researchers at the University of Geneva discovered that a protein of Pseudomonas aeruginosa, called Host factor q (Hfq), reacts…
Articles by Daniela Semedo, PhD
Pharmaxis announced that Bronchitol (mannitol) has been approved in Russia for the treatment of both pediatric and adult patients with cystic…
Penn State researchers developed a fluorescent sensor able to easily and accurately detect salt concentrations in the sweat or…
Raptor Pharmaceuticals recently presented the results of a meta-analysis comparing the effectiveness of inhaled antibiotics for cystic fibrosis (CF)…
Proteostasis Therapeutics announced it is now enrolling cystic fibrosis patients and healthy adults in two Phase 1 clinical trials evaluating its…
The Japanese Patent Office has granted AmpliPhi Biosciences a patent for the “Beneficial effects of bacteriophage treatments”…
New four-dimensional computed tomography (4DCT) for lung scans, developed by Professor Andreas Fouras at Monash University, offers the potential to…
The Cystic Fibrosis Foundation hosted more than 100 researchers from various fields at its “New Technologies Advancing Toward a One-time Cure” conference last…
ProQR Therapeutics announced that QR-010, an inhaled therapy it is developing to treat cystic fibrosis patients with the ∆F508 mutation in the CFTR…
Pharmaxis announced that it has completed recruiting adult patients with cystic fibrosis (CF) for its large and potentially pivotal Phase 3 clinical trial…